Exponent to Announce First Quarter of Fiscal Year 2023 Results and Host Quarterly Conference Call on April 27, 2023
04 April 2023 - 6:05AM
Exponent, Inc. (Nasdaq:EXPO), today announced that it will report
first quarter of fiscal year 2023 financial results for the period
ended March 31, 2023 following the close of the market on Thursday,
April 27, 2023. On that day, Dr. Catherine Corrigan, Chief
Executive Officer and President, and Richard Schlenker, Executive
Vice President and Chief Financial Officer, will host a conference
call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the
Company’s business and financial results.
Event: |
Exponent, Inc. First Quarter of Fiscal Year 2023 Financial
Results Conference Call |
Date: |
Thursday, April 27, 2023 |
Time: |
4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time |
Live Call: |
(844) 481-2781 or (412) 317-0672 |
|
|
Exponent will also offer a live and archived webcast of the
conference call, accessible from the Investor Relations section of
the company's website, http://www.exponent.com/investors. A
telephonic replay of the conference call will be available until
Thursday, May 4, 2023 by dialing (877) 344-7529 or (412) 317-0088
and entering passcode 6019209#.
About ExponentExponent is an engineering and
scientific consulting firm providing solutions to complex problems.
Exponent's interdisciplinary organization of scientists,
physicians, engineers, and business consultants draws from more
than 90 technical disciplines to solve the most pressing and
complicated challenges facing stakeholders today. The firm
leverages over 50 years of experience in analyzing accidents and
failures to advise clients as they innovate their technologically
complex products and processes, ensure the safety and health of
their users, and address the challenges of sustainability.
Exponent may be reached at (888) 656-EXPO, info@exponent.com, or
www.exponent.com.
Exponent (NASDAQ:EXPO)
Historical Stock Chart
From Jan 2025 to Feb 2025
Exponent (NASDAQ:EXPO)
Historical Stock Chart
From Feb 2024 to Feb 2025